Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
2 hedge funds and large institutions have $6K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
33% less funds holding
Funds holding: 3 → 2 (-1)
97% less capital invested
Capital invested by funds: $233K → $6K (-$227K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$5.86K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$232K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $5K | +$5.86K | +16,823 | +1,871% |
|
2
Osaic Holdings
Scottsdale,
Arizona
| $1K | – | – | – |
|
|
AFM
3
Anson Funds Management
Dallas,
Texas
| – | -$232K | -86,299 | Closed |
|
PHIOW Hedge Fund Activity: Q1 2021 in Review
2 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q1 2021, worth a combined $6K — down 97% from $233K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of PHIOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $5.86K. The largest seller was Anson Funds Management, exiting entirely with an estimated $232K sold.
- 2 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q1 2021, down from 3 in Q4 2020.
- Funds reported $6K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q1 2021, down 97% quarter-over-quarter.
- 0 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q1 2021 and 1 closed out, a net change of -1 holder.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q1 2021 was UBS Group, an estimated $5.86K added.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q1 2021 was Anson Funds Management, an estimated $232K sold.
Based on aggregated 13F filings for Q1 2021.